{
  "model": "google/gemma-3-27b-it:free",
  "content": ":\n```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Lupus Nephritis\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"N03.2\",\n        \"reasoning\": \"The constellation of symptoms \u2013 intermittent hematuria, dysuria, flank pain, proteinuria (3+), RBC casts, decreased urine output, elevated creatinine (eGFR 42), low C3/C4 complement levels, positive ANA with a homogeneous pattern, and fatigue \u2013 strongly suggests a systemic autoimmune process affecting the kidneys. The patient's age, recent immigrant status (potentially exposing to different environmental triggers), and family history of kidney problems support this. Recurrent 'kidney stones' in the past could have been early manifestations of lupus nephritis. While the urine cultures were negative, this is common in lupus nephritis as it's not typically a bacterial infection.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"IgA Nephropathy\",\n            \"confidence\": 0.7,\n            \"icd_code\": \"N03.0\",\n            \"reasoning\": \"IgA nephropathy can present with recurrent hematuria, flank pain, and proteinuria. However, the low C3/C4 levels and positive ANA make this less likely than lupus nephritis.  The dysmorphic RBCs are consistent with glomerular disease, seen in both conditions.\"\n        },\n        {\n            \"name\": \"Post-infectious Glomerulonephritis\",\n            \"confidence\": 0.5,\n            \"icd_code\": \"N03.9\",\n            \"reasoning\": \"Can present with hematuria, proteinuria, and decreased renal function. However, the chronic, intermittent nature of the symptoms (6 months) and lack of recent reported infection make this less probable. The low complement levels are also less typical of post-infectious glomerulonephritis.\"\n        },\n        {\n            \"name\": \"Interstitial Nephritis (Drug-Induced)\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"N03.1\",\n            \"reasoning\": \"Given the patient's occupation as a chemistry graduate student and exposure to solvents, drug-induced interstitial nephritis is a possibility. However, the systemic symptoms (edema, fatigue) and positive ANA are less consistent with this diagnosis.\"\n        }\n    ],\n    \"key_findings\": [\"Proteinuria 3+\", \"RBC casts\", \"Decreased eGFR (42 mL/min/1.73m\u00b2)\", \"Low C3/C4\", \"Positive ANA\", \"Dysmorphic RBCs\"],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Anti-dsDNA antibody\",\n            \"purpose\": \"To further evaluate for systemic lupus erythematosus (SLE).\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Anti-Smith antibody\",\n            \"purpose\": \"To further evaluate for SLE.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"ANCA panel\",\n            \"purpose\": \"Rule out ANCA-associated vasculitis.\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"24-hour urine protein collection\",\n            \"purpose\": \"Quantify proteinuria.\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Renal biopsy\",\n            \"purpose\": \"Definitive diagnosis and assessment of disease severity.\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\"Initiate renal protective measures\", \"Fluid management to address edema\"],\n        \"medications\": [\n            {\n                \"drug\": \"ACE inhibitor or ARB\",\n                \"dose\": \"Titrated to tolerance\",\n                \"route\": \"Oral\",\n                \"duration\": \"Ongoing\",\n                \"rationing\": \"Reduce proteinuria and slow disease progression\"\n            },\n            {\n                \"drug\": \"Prednisone\",\n                \"dose\": \"Initiate at 0.5-1mg/kg/day, taper based on response\",\n                \"route\": \"Oral\",\n                \"duration\": \"Variable, dependent on disease activity\",\n                \"rationing\": \"Immunosuppression to control inflammation\"\n            }\n        ],\n        \"monitoring\": [\"Creatinine\", \"eGFR\", \"Urine protein\", \"Blood pressure\", \"C3/C4 levels\", \"Complete blood count\"],\n        \"consultations\": [\n            {\n                \"specialty\": \"Nephrology\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Evaluation and management of suspected lupus nephritis, biopsy coordination.\"\n            },\n            {\n                \"specialty\": \"Rheumatology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Confirmation of SLE diagnosis and long-term management.\"\n            }\n        ]\n    },\n    \"red_flags\": [\"Rapidly declining renal function\", \"Nephrotic range proteinuria\", \"Severe hypertension\", \"Signs of active systemic lupus (e.g., rash, arthritis)\"],\n    \"patient_education\": [\"Importance of medication adherence\", \"Signs and symptoms of disease flare-ups\", \"Need for regular follow-up appointments\"],\n    \"follow_up\": {\n        \"timing\": \"Within 1 week with Nephrology and Rheumatology\",\n        \"conditions\": \"Worsening renal function, development of new symptoms, non-compliance with medications\"\n    },\n    \"confidence\": 0.8,\n    \"uncertainties\": [\"The exact etiology of the recurrent 'kidney stones' in the past is unknown due to lack of documentation.\", \"The extent of systemic involvement of lupus, if confirmed, needs further evaluation.\"]\n}\n```",
  "response_time": 1754942375.285147,
  "cached": false,
  "case_id": "Case_13",
  "timestamp": "2025-08-11T21:59:35.285153",
  "tokens_used": 2589,
  "from_34_list": true
}